Seattle Genetics

SGEN

SGEN
Seattle Genetics Stock Quote
$173.09 -$2.57 -1.5%
Price as of September 18, 2020, 11:39 a.m. EDT View Interactive SGEN Charts

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Interactive Chart


News & Analysis: Seattle Genetics

The Fool has written over 200 articles on Seattle Genetics.

All

Market Moves

Earnings









Is Seattle Genetics Stock a Buy?

With a new drug on the market and another being reviewed by the FDA, Seattle Genetics’ revenue potential is climbing.